Committed to Global Cystic Fibrosis Research

With any cystic fibrosis program, building and maintaining strong relationships is critical. For this reason, we make a concerted effort to keep our cross-functional cystic fibrosis study teams together over the course of multiple studies—aiding development of our therapeutic indication expertise and strengthening our relationships with key opinion leaders and clinical sites in North America and Europe.

Why Choose Rho?

Rho understands what it takes to successfully execute global cystic fibrosis (CF) studies. Not only have we conducted studies of both pulmonary and gastrointestinal outcomes through inpatient and outpatient studies, we also have extensive relationships with the key CF clinical trials networks – the Cystic Fibrosis Foundation Therapeutics Development Network (CFF TDN), the European Cystic Fibrosis Society (ECFS) Clinical Trials Network, and Cystic Fibrosis Canada Accelerating Clinical Trials (CF CanACT) – including a comprehensive understanding of their protocol assessment and feasibility processes.

Expertise in Action

Our team of CF experts average 10+ years dedicated to CF clinical research and have experience coordinating standard of care with study-specific procedures and assessments, interacting with multidisciplinary care teams, Non-CFTR modulator studies, and working with the CFF TDN data safety monitoring board (DSMB). Our dedication and passion to find a cure extends to working with patient advocacy groups as well, including a strong partnership with Emily’s Entourage where the focus is to find cures for the last 10% of CF patients. With our proven success in CF trial management, strong site relationships, and global reach, Rho is the right CRO partner to help you navigate the complexities involved with CF studies.

Some highlights include:

• Long-standing relationships with 75+ CF research centers globally, including those in the Cystic Fibrosis Foundation Therapeutics Development Network (CFF TDN), European Cystic Fibrosis Society Clinical Trials Network (ECFS CTN), and Cystic Fibrosis Canada Accelerating Clinical Trials (CF CanACT) network

• Strong partnership with advocacy groups including Emily’s Entourage, whose focus is to find cures for the last 10%
• Rho is the only CRO to form a partnership with the CFF TDN
• Rho conducts quarterly meetings with CFF TDN

Some of the Sites We’ve Worked With Include

• University of Alabama; Birmingham, AL
• Johns Hopkins University; Baltimore, MD
• Virginia Commonwealth University; Richmond, VA
• Northwestern University; Chicago, IL
• University of California San Diego; San Diego, CA
• University Hospitals Cleveland Medical Center; Cleveland, OH
• Children’s Hospital Colorado; Aurora, CO
• University of Kansas Medical Center; Kansas City, KS
• Nationwide Children’s Hospital; Columbus, OH
• National Jewish Health; Denver, CO
• University of Florida; Gainesville, FL
• University of North Carolina at Chapel Hill; Chapel Hill, NC
• Hershey Medical Center Pennsylvania State University; Hershey, PA
• Boston Children’s Hospital; Boston, MA
• University of Pennsylvania; Philadelphia, PA
• Children’s Hospital of Pittsburgh of UPMC; Pittsburgh, PA
• Żagiel-Med Szpital; Lublin, Poland
• Medical University of South Carolina; Charleston, SC
• Cassia Villa Medica ul Słoneczna; Rabka-Zdrój, Poland
• Tüdőgyógyintézet Törökbálint; Törökbálint, Hungary
• Podkarpacki Osrodek Pulmonologii i Alergologii; Rzeszów, Poland
• Sanatorium “ Kamienny Potok”; Sopot, Poland
• Hospital La Fe de Valencia; Valencia, Spain
• Pediatric Pulmonary Medicine: Department at the Ruth Rapport Children’s Hospital; Haifa, Israel
• Stollery Children’s Hospital/University of Alberta; Edmonton, AB
• Hadassah University Hospital Ein Kerem; Jerusalem, Israel
• Magyar Imre Kórház; Ajka, Hungary
• Unity Health Toronto – St. Michael’s Hospital; Toronto, ON
• McGill University Health Center; Montreal, QU

CF Experience